Sign in
4

Changes in Ownership

Lexaria Bioscience Corp. Filed Acc 0001312326-19-000002

Options or other derivatives

  • Director acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Baxter Nicholas W Director 2019-05-06 Grant or award · Stock Options +150,000 $0.99 $148,500 260,000 D: show line 1 in the form
Loading xslF345X03/primary_doc.xml…